Zymergen Inc's

Name: Zymergen Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ZY Sales vs. its Competitors Q2 2022

Comparing the current results to its competitors, Zymergen Inc reported Revenue decrease in the 2 quarter 2022 year on year by -55.26 %, despite the revenue increase by the most of its competitors of 2401.31 %, recorded in the same quarter.

• List of ZY Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Zymergen Inc., faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< ZY Stock Performance Comparisons

<< See the full list of ZY competitors

Overall company Market Share Q2 2022

Overall company, revenue fell by -55.26 % and company lost market share, to approximately 1.79 %. << More on ZY Market Share.

*Market share is calculated based on total revenue.

ZY's Stock Performance relative to its Competitors

Publicly Traded Peers of Zymergen Inc.

Ginkgo Bioworks Holdings Inc
Share Performance

-18.24%

30 Days

Ginkgo Bioworks Holdings Inc

Profile

Ginkgo Bioworks Holdings Inc is a biotechnology company that focuses on using genetic engineering to develop new organisms for various industries. Their business model includes partnering with companies to create custom-designed organisms for applications such as fragrance production, food and beverage, agriculture, and pharmaceuticals. They generate revenue through collaborations, licensing agreements, and providing access to their platform for organism design and development.

More about Ginkgo Bioworks Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 413.966 mill.	$ 141.311 mill.	$ -304.393 mill.

Sources: Zymergen Inc.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, July 7, 2026 10:25 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Zymergen Inc. versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.